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Placental angiogenesis is a pivotal process that estab-
lishes fetomaternal circulation, ensures efficient maternofetal
exchanges, plays a key mechanistic role in the elaboration
of the placental villous tree, and contributes to the overall
development of the placenta throughout pregnancy. Failure
in these processes is tightly linked to the development
of placental pathologies such as preeclampsia (PE), early
pregnancy loss, and intrauterine growth restriction (IUGR).
It is now well established that a close relationship exists
between embryonic development and the degree of placental
angiogenesis. A key discovery in the investigation of placental
pathologies was the understanding that major phenotypes of
PE are associated with dysregulation in angiogenic factors.
During the last decade multiple new key angiogenic pro-
teins have been reported to play crucial roles in placental
angiogenesis; these include netrins, EG-VEGF (endocrine
gland derived endothelial growth factor), and angiogenin.
Furthermore, placental angiogenesis appears to also be reg-
ulated by specific microRNAs (miRNAs), deregulations of
which have also been shown to be associated with pregnancy
pathologies. By affecting placental angiogenesis, numerous
insults have been shown to influence pregnancy outcomes.
These include (i) oxidative stress, (ii) hyperglycemia, and (iii)
failure in immune system adaptations to pregnancy, such
as the presence of antiphospholipid antibodies (aPL) and/or
soluble Mic (sMIC).
In the present scope authors reported new findings in the
field of placental angiogenesis, discussed the advancements
made in the diagnosis of pathologies reported to be associated
with placental angiogenesis, and brought new insights into
the processes of vasculogenesis and angiogenesis occurring
throughout pregnancy in the placenta. More importantly,
regulators of the key protagonists of vascular and angiogenic
processes have been reported and their roles discussed.
The reviews by M. Dakouane-Giudicelli et al., N. Pavlov
et al., and N. Alfaidy et al. reported the role of three newly
discovered angiogenic placental factors, netrin-1 and netrin-
4, angiogenin, and EG-VEGF, respectively. M. Dakouane-
Giudicelli et al. highlighted the opposite role that netrin-1 and
netrin-4 might play in normal and pathological pregnancies.
Netrin-1 and netrin-4 have been found to be either proangio-
genic or antiangiogenic factors in the human placenta. These
opposite effects appear to be related to the endothelial cell
phenotype studied and seem also to depend on the type of
receptor to which each netrin binds.
N. Pavlov et al. demonstrated that the proangiogenic
protein, angiogenin, might play a key role in placental
blood vessel formation as well as in the cross talk between
trophoblasts and endothelial cells. The review by N. Alfaidy
et al. recapitulates EG-VEGF mediated-angiogenesis within
the placenta and at the fetomaternal interface and proposes
that its deregulation might contribute to the pathogenesis
of several placental pathologies including IUGR and PE.
More importantly, this article argues for EG-VEGF clinical
relevance as a potential biomarker of the onset of pregnancy
pathologies and discusses its potential usefulness for future
therapeutic directions.
In a second set of reviews of the scope Dr. R. D. Pereira
et al. reported the effect of oxidative stress on the expression
of a number of transcription factors that are important in
mediating angiogenesis and stressed that the understanding
of how oxidative stress affects redox-sensitive transcription
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factors within the placenta may elucidate potential therapeu-
tic targets to correct abnormal placental angiogenesis and
function. In the same context, S. Cvitic et al. described the
major regulators of placental angiogenesis and demonstrated
how the diabetic environment in utero alters their expression.
In relation to immune placental pathologies that affect
placental vascularization and angiogenesis, J. B. Haumonte
et al. work suggests that detection of sMIC molecules in
maternal plasma may constitute a hallmark of altered mater-
nal immune functions associated with vascular disorders
that contributes to poor pregnancy outcomes, notably by
impairing NK-cell mediated production of IFN gamma,
an essential cytokine favoring vascular modeling. In the
same perspective, O. Paulmyer-Lacroix et al. highlighted
the menace of antiphospholipid antibodies (aPL) positive
patients on placental vascular development during implan-
tation. These findings propose aPL assessment, in particular
a𝛽2GPI IgA antibodies, as a novel therapeutic strategy to
improve pregnancy outcome.
Finally,M. Tsochandaridis et al. highlighted amajor topic
of interest for clinicians and biologists that concern maternal
and fetal monitoring and their importance in predicting
pregnancy complications. Her work has addressed the poten-
tial role of circulating as well as placental miRNAs that are
associated with abnormal angiogenesis.
Overall the present scope on this special issue summa-
rizes key aspects of placental angiogenesis during normal
and pathological pregnancies. The scope will expand our
knowledge in this field and allow better understanding of the
associated mechanisms to placental angiogenesis.
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